Filing Details
- Accession Number:
- 0001181431-14-007429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 18:02:51
- Reporting Period:
- 2014-02-13
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 18:02:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880 | Evp, Chief Drug Dev&Medical Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-13 | 33,055 | $11.98 | 37,356 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 61,096 | $3.11 | 98,452 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 47,913 | $9.41 | 146,365 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 25,862 | $11.98 | 172,227 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 12,300 | $9.41 | 184,527 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 9,138 | $11.98 | 193,665 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 1,945 | $11.98 | 195,610 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-13 | 191,309 | $66.38 | 4,301 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 24,787 | $9.41 | 29,088 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 14,583 | $13.34 | 43,671 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 417 | $13.34 | 44,088 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-14 | 39,787 | $66.13 | 4,301 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 33,055 | $0.00 | 33,055 | $11.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 61,096 | $0.00 | 61,096 | $3.11 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 47,913 | $0.00 | 47,913 | $9.41 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 25,862 | $0.00 | 25,862 | $11.98 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 12,300 | $0.00 | 12,300 | $9.41 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 9,138 | $0.00 | 9,138 | $11.98 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 1,945 | $0.00 | 1,945 | $11.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-14 | 24,787 | $0.00 | 24,787 | $9.41 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-14 | 14,583 | $0.00 | 14,583 | $13.34 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-14 | 417 | $0.00 | 417 | $13.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 0 | 2016-01-26 | No | 4 | M | Direct | |
| 24,787 | 2017-01-20 | No | 4 | M | Direct | |
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 0 | 2017-01-20 | No | 4 | M | Direct | |
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 0 | 2015-02-07 | No | 4 | M | Direct | |
| 0 | 2017-01-20 | No | 4 | M | Direct | |
| 0 | 2017-05-17 | No | 4 | M | Direct | |
| 0 | 2017-05-17 | No | 4 | M | Direct |
Footnotes
- Beginning February 8, 2008, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $65.42-$67.41.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sales prices ranged from $65.50-$66.56.
- Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning January 21, 2010, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning May 18, 2010, options become exercisable in 25 installments, with the first 33.33% vesting on January 21, 2011 and the remainder vesting monthly over two years.
Billionaire Hedge Funds
